Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular Alterations in Pancreatic Cancer: Transfer to the Clinic.

International journal of molecular sciences - 19 Feb 2021

Rodríguez Gil Yolanda, Jiménez Sánchez Paula, Muñoz Velasco Raúl, García García Ana, Sánchez-Arévalo Lobo Víctor Javier

Abstract excerpt

Pancreatic ductal adenocarcinoma (PDA) is the most common cancer of the exocrine pancreas and probably the tumor that has benefited the least from clinical progress in the last three decades. A consensus has been reached regarding the histologic classification of the ductal preneoplastic lesions (pancreatic intra-epithelial neoplasia-PanIN) and the molecular alterations associated with them. Mutations in KRAS and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Epigenesis, Genetic
Share to Genetic Heterogeneity

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Molecular Targeted Therapy

Share to Pancreatic Neoplasms

Share to Translational Research, Biomedical

Source

Open in PubMed Open full text

Identifiers

PMID: 33669845
DOI: 10.3390/ijms22042077
PMCID: PMC7923218

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular Alterations in Pancreatic Cancer: Transfer to the Clinic.PMID 33669845Read ↗

Pancreatic adenocarcinomas without KRAS, TP53, CDKN2A and SMAD4 mutations and CDKN2A/CDKN2B copy number alterations: a review of the genomic landscape to unveil therapeutic avenues.Semantic proximity Read ↗

Mutations in key driver genes of pancreatic cancer: molecularly targeted therapies and other clinical implications.Semantic proximity Read ↗

Molecular Pathology of Pancreatic Cancer: From Bench-to-Bedside TranslationSemantic proximity Read ↗

An overview of genetic mutations and epigenetic signatures in the course of pancreatic cancer progression.Semantic proximity Read ↗

Molecular Pathology of Pancreatic Ductal AdenocarcinomaSemantic proximity Read ↗

Genetic landscape of pancreatic cancer: a narrative review.Semantic proximity Read ↗

Pancreatic Cancer: Genetics, Screening, Prevention, and Treatment.Semantic proximity Read ↗

Molecular Pathogenesis of Pancreatic Cancer.Semantic proximity Read ↗

Molecular biology of pancreatic cancer.Semantic proximity Read ↗

Translational genomics in pancreatic ductal adenocarcinoma: A review with re-analysis of TCGA dataset.Semantic proximity Read ↗

Genetic and Epigenetic Alterations in Pancreatic CarcinogenesisSemantic proximity Read ↗

Toward the goal of personalized therapy in pancreatic cancer by targeting the molecular phenotype.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.